已收录 268921 条政策
 政策提纲
  • 暂无提纲
Immune cells as tumor drug delivery vehicles
[摘要] This review article describes the use of immune cells as potential candidates to deliver anti-cancer drugs deep within the tumor microenvironment. First, the rationale of using drug carriers to target tumors and potentially decrease drug-related side effects is discussed. We further explain some of the current limitations when using nanoparticles for this purpose. Next, a comprehensive step-by-step description of the migration cascade of immune cells is provided as well as arguments on why immune cells can be used to address some of the limitations associated with nanoparticle-mediated drug delivery. We then describe the benefits and drawbacks of using red blood cells, platelets, granulocytes, monocytes, macrophages, myeloid-derived suppressor cells, T cells and NK cells for tumor-targeted drug delivery. An additional section discusses the versatility of nanoparticles to load anti-cancer drugs into immune cells. Lastly, we propose increasing the circulatory half-life and development of conditional release strategies as the two main future pillars to improve the efficacy of immune cell-mediated drug delivery to tumors.
[发布日期] 2020-11-10 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Targeted drug delivery;Immune cells;Tumor microenvironment;Circulatory half-life;Conditional release [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文